1[2]Pendas A, Knaeuper V, Puente X. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics. chromosomal location, and tissue distribution. Journal of Biological Chemistry, 1997,272 (7) .. 4281-4286.
2[3]Luca M, Huang S, Gershenwald J. Expression Of Interleukin8 By Human Melanomacells up-regulates MMP- 2 activity and increases tumor growth and metastasis. Am J Pathol, 1997,151 (4): 1105-1113.
3[4]Sato H, Takino T, Okada Y. A matrix metalloproteinase expressed on the surface of invasivetumour cells. Nature, 1994,370 (6484), 61-65.
4[6]David E, Kleiner, William G. Quantitative zymography : detection of picogram quantities of gelatinases. Analitical Biochemistry, 1994, 218: 325-329.
5[7]Kim NW, Piatyszek M, Prowse K, et al. Specific association of human telomerase activity with immortal cells and cancer. Science, 1994, 266: 2011-2015.
6[8]Martinella C, Nawrocki B, Gilles C, et al. Matrix metalloproteinases in bronchopulmonary carcinomas. Histol-Histopathol,1999, 14 (3): 839-843.
7[9]Gonzalezavila G, Iturria C, Vadillo F, et al. 72-kD (MMP2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells. Pathobiology, 1998, 66 (1): 5-16.
8[10]Suzuki M, Iizasa T, Fujisawa T, et al. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non - small - cell lung cancer. Invasion - and - Metastasis,1999, 18 (3): 134-141.
9[11]Suzuki M, Iizasa T, Yamaguchi Y, et aL.lmmunohistochemical study on matrix metalIoproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in lung cancer .Japanese JournalofLungCancer, 1996, 36 (7): 937-943.
10[12]Kodate M, Kasai T, Hashimoto H, et al. Expression Of Matrix Metalloproteinase (gelatinase) In T1 adenocarcinoma of the lung. Pathol Iht, 1997, 47 (7) : 461-469.